Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
37.85
79.22
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Hangzhou Tigermed Consulting Co Ltd
Accrued Liabilities
Hangzhou Tigermed Consulting Co Ltd
Accrued Liabilities Peer Comparison
Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Accrued Liabilities
ÂĄ346m
|
CAGR 3-Years
30%
|
CAGR 5-Years
27%
|
CAGR 10-Years
38%
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Accrued Liabilities
ÂĄ2.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Accrued Liabilities
ÂĄ732.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Accrued Liabilities
ÂĄ393.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Genscript Biotech Corp
HKEX:1548
|
Accrued Liabilities
$165.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Accrued Liabilities
ÂĄ74.9m
|
CAGR 3-Years
109%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Hangzhou Tigermed Consulting Co Ltd's Accrued Liabilities?
Accrued Liabilities
346m
CNY
Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Accrued Liabilities amounts to 346m CNY.
What is Hangzhou Tigermed Consulting Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
38%
Over the last year, the Accrued Liabilities growth was 21%. The average annual Accrued Liabilities growth rates for Hangzhou Tigermed Consulting Co Ltd have been 30% over the past three years , 27% over the past five years , and 38% over the past ten years .